The immunohistochemical expression of c-Met is an independent predictor of survival in patients with glioblastoma multiforme
dc.contributor.buuauthor | Ölmez, Ömer Fatih | |
dc.contributor.buuauthor | Çubukçu, Erdem | |
dc.contributor.buuauthor | Evrensel, Türkkan | |
dc.contributor.buuauthor | Kurt, Mera | |
dc.contributor.buuauthor | Avcı, Nilüfer | |
dc.contributor.buuauthor | Tolunay, Şahsine | |
dc.contributor.buuauthor | Bekâr, Ahmet | |
dc.contributor.buuauthor | Deligönül, Adem | |
dc.contributor.buuauthor | Hartavi, Mustafa | |
dc.contributor.buuauthor | Alkis, Nihan | |
dc.contributor.buuauthor | Manavoǧlu, Osman | |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Onkoloji Anabilim Dalı. | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Nöropatoloji Bölümü. | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Nöroşirürji Bölümü. | tr_TR |
dc.contributor.orcid | 0000-0003-1637-910X | tr_TR |
dc.contributor.orcid | 0000-0002-9732-5340 | tr_TR |
dc.contributor.researcherid | AAI-1612-2021 | tr_TR |
dc.contributor.researcherid | AAA-3961-2020 | tr_TR |
dc.contributor.researcherid | AAJ-1027-2021 | tr_TR |
dc.date.accessioned | 2023-05-26T07:40:19Z | |
dc.date.available | 2023-05-26T07:40:19Z | |
dc.date.issued | 2013-09 | |
dc.description | Bu çalışma, 27 Eylül- 01 Ekim 2013 tarihleri arasında Amsterdam[Hollanda]’da düzenlenen European Cancer Congress 2013 - 17. ECCO / 38. ESMO / 32. ESTRO’da bildiri olarak sunulmuştur. | tr_TR |
dc.description.sponsorship | European Conf Clin Oncol | en_US |
dc.description.sponsorship | European Soc Therapeut Radiol & Oncol | en_US |
dc.description.sponsorship | European Soc Med Oncol | en_US |
dc.description.sponsorship | European Soc Surg Oncol | en_US |
dc.description.sponsorship | European Assoc Canc Res | en_US |
dc.description.sponsorship | European Oncol Nursing Soc | en_US |
dc.description.sponsorship | European Soc Paediat Oncol | en_US |
dc.identifier.citation | Ölmez, O. F. vd. (2013). “The immunohistochemical expression of c-Met is an independent predictor of survival in patients with glioblastoma multiforme”. European Journal of Cancer, 49(Supplement 2), S793-S793. | en_US |
dc.identifier.endpage | S793 | tr_TR |
dc.identifier.issn | 0959-8049 | |
dc.identifier.issn | 1879-0852 | |
dc.identifier.issue | Supplement 2 | en_US |
dc.identifier.startpage | S793 | tr_TR |
dc.identifier.uri | http://hdl.handle.net/11452/32800 | |
dc.identifier.volume | 49 | tr_TR |
dc.identifier.wos | 000326843605114 | tr_TR |
dc.indexed.wos | SCIE | en_US |
dc.indexed.wos | CPCIS | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier | en_US |
dc.relation.journal | European Journal of Cancer | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası | tr_TR |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Oncology | en_US |
dc.subject.wos | Oncology | en_US |
dc.title | The immunohistochemical expression of c-Met is an independent predictor of survival in patients with glioblastoma multiforme | en_US |
dc.type | Meeting Abstract | |
dc.wos.quartile | Q1 | en_US |
Files
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: